5 Stocks With Poor Analyst Earnings Revisions — GLYC AMCC SOL MSO IFT

Advertisement

This week, these five stocks have the worst ratings in Analyst Earnings Revisions, one of the eight Fundamental Categories on Portfolio Grader.

GLYC also gets F’s in Equity and Sales Growth. For more information, get Portfolio Grader’s complete analysis of GLYC stock.

Applied Micro Circuits Corporation (AMCC) provides semiconductor solutions for the enterprise, telecom and consumer/small medium business (SMB) markets. AMCC also gets F’s in Earnings Momentum, Equity and Sales Growth. Since January 1, AMCC has fallen 9.2%. This is worse than the Nasdaq, which has remained flat. For more information, get Portfolio Grader’s complete analysis of AMCC stock.

ReneSola Ltd. Sponsored ADR (SOL) develops, manufactures and sells solar wafers, which are thin sheets of crystalline silicon material mainly made by slicing monocrystalline or multicrystalline ingots. SOL gets F’s in Equity and Cash Flow as well. The price of SOL is down 25% since the first of the year. For more information, get Portfolio Grader’s complete analysis of SOL stock.

Martha Stewart Living Omnimedia, Inc. (MSO) creates original how-to content and related products for homemakers and other consumers. MSO also gets an F in Sales Growth. For more information, get Portfolio Grader’s complete analysis of MSO stock.

Imperial Holdings, Inc. (IFT) is a specialty finance company with a focus on providing financing for individual life insurance policies and purchasing structured settlements. IFT also gets F’s in Earnings Growth, Earnings Momentum, Cash Flow, Operating Margin Growth and Sales Growth. Shares of the stock have declined 1.6% since January 1. The stock’s trailing PE Ratio is 85.70. For more information, get Portfolio Grader’s complete analysis of IFT stock.

Louis Navellier’s proprietary Portfolio Grader stock ranking system assesses roughly 5,000 companies every week based on a number of fundamental and quantitative measures. Stocks are given a letter grade based on their results — with A being “strong buy,” and F being “strong sell.” Explore the tool here.


Article printed from InvestorPlace Media, https://investorplace.com/2015/01/5-stocks-with-poor-analyst-earnings-revisions-glyc-amcc-sol-mso-ift-glyc-amcc-sol/.

©2024 InvestorPlace Media, LLC